Media Summary: Michael Atkins, MD, of Georgetown University, Washington DC, outlines the Elizabeth Plimack, MD, MS, Fox Chase Cancer Centre, Philadelphia, PA, gives an overview of Thomas Powles, MBBS, MRCP, MD, of Barts Cancer Institute, London, UK, talks about the rationale and
Promising Results For Axitinib And - Detailed Analysis & Overview
Michael Atkins, MD, of Georgetown University, Washington DC, outlines the Elizabeth Plimack, MD, MS, Fox Chase Cancer Centre, Philadelphia, PA, gives an overview of Thomas Powles, MBBS, MRCP, MD, of Barts Cancer Institute, London, UK, talks about the rationale and Brian Rini, MD, from the Cleveland Clinic Taussig Cancer Institute on the In this video, Matthew Milowsky, MD, of the UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, shares insights on ... Matthew Zibelman, MD, Fox Chase Cancer Center, Philadelphia, PA, discusses
Brian Rini, MD, associate professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University ... Brian I. Rini, MD, professor of Medicine, Cleveland Clinic, discusses the efficacy of pembrolizumab (Keytruda) and Nazli Dizman, MD, an Internal Medicine Resident at Yale University, discusses the combination of pembrolizumab and Dr Martin Voss, (Memorial Sloan Kettering Cancer Centre, New York City, USA) talks to ecancertv at ASCO GU 2015 on part 1 of ... Join study principal investigator Brian I. Rini, MD, for an in-depth discussion on Phase 3 trial Dr Motzer speaks with ecancer at ESMO 2018 in Munich about
